Nachrichten zur Bristol-Myers Squibb Co Aktie

The Zacks Analyst Blog Highlights: Broadcom, Amgen, NVIDIA, Bristol-Myers and Restaurant Brands

The Zacks Analyst Blog Highlights: Broadcom, Amgen, NVIDIA, Bristol-Myers and Restaurant Brands...…

Bristol-Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Bristol-Myers Squibb (BMY) closed at $47.81, marking a -0.84% move from the previous day....…

Is It Too Late to Buy Celgene Stock-

The clock is ticking for Celgenes acquisition by Bristol-Myers Squibb. But is Celgene still a stock worth buying?...…

Price target on Bristol-Myers stock cut to $51 at UBS

Analysts at UBS cut their price target on shares of Bristol-Myers Squibb Co. on Thursday to $51 from $55…

Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and Northrop

Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and Northrop...…

Bristol-Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy-

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca

The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca...…

Bristol-Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

Bristol-Myers Squibb (BMY) closed at $46.15 in the latest trading session, marking a -1.03% move from the prior day....…

Merger uncertainty and impending trials for Bristol-Myers leave investors in limbo

Investors are taking a wait-and-see approach to Bristol-Myers Squibb Co., according to Credit Suisse....…

Investors Playing ‘Wait and See’ on Changes at Bristol-Myers

Credit Suisse analyst Vamil Divan says investors see an upside in the company’s merger with Celgene, but as yet have…

Bristol-Myers Squibb And AbbVie: Pharma Dividend Opportunities With Large Margins Of Safety

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Stock Moves -1.11%: What You Should Know

In the latest trading session, Bristol-Myers Squibb (BMY) closed at $45.37, marking a -1.11% move from the previous day....…

Why Is Bristol-Myers (BMY) Up 2.6% Since Last Earnings Report-

Bristol-Myers (BMY) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Final trades: Bristol-Myers, Boeing, Copart, Gilead & Kratos Defense

The "Halftime Report" traders give their top stocks to watch for the second half....…

Mercks Keytruda Vs. Bristol-Myers Squibbs Opdivo In Q1 And Beyond

Two big pharma titans are battling for supremacy in the field of oncology immunotherapy. read more...…

Bristol-Myers Squibb: Share Repurchases No Benefit To Shareholders

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

As Bristol-Myers Continues to Slump, a Director Is Buying Up Shares

Ted Samuels paid $236,440 for 5,000 shares last week. It’s the first open-market purchase of Bristol-Myers stock by an insider…

Argus Questions Logic Behind Bristol-Myers Proposed Celgene Buy, Steps To Sidelines

Bristol-Myers Squibb Co (NYSE: BMY)s quest to expand its oncology franchise through its proposed acquisition of Celgene Corporation…

Top Analyst Upgrades and Downgrades: Alibaba, Baidu, Bristol-Myers, Cimarex, Deere, Deutsche Bank, Micron, NeoPhotonics, Target, United Continental and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb: A Long Idea for Aggressive Traders Only

Um den gesamten Artikel unter realmoney.thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks.com featured highlights include: BlackRock, Northrop, Progressive, Interpublic Group and Bristol-Myers

Zacks.com featured highlights include: BlackRock, Northrop, Progressive, Interpublic Group and Bristol-Myers...…

Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems

Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems...…

Bristol-Myers Squibbs Opdivo Stumbles In Late-Stage Brain Cancer Study

Bristol-Myers Squibb Co (NYSE: BMY), which is prepping for its purchase of Celgene Corporation (NASDAQ: read more...…

Bristol-Myers Opdivo fails late-stage brain cancer trial

Bristol-Myers Squibb Co said on Thursday its immunotherapy Opdivo failed to meet the main goal of a late-stage trial testing it in…

Bristol Myers Squibb priced 9 international bonds issues in a total amount of USD 19,000m

May 07, 2019 global biopharmaceutical company Bristol Myers Squibb priced 9 international bonds issues in total amount of USD 16,000m.…

Bristol-Myers Squibb Is Selling $19 Billion of Bonds to Buy Celgene

The bond sale is on track to be the biggest so far this year, according to Dealogic data....…

Bristol-Myers Prepares Large Bond Sale To Fund Celgene Purchase

Bristol-Myers Squibb Co. is planning to sell around $20 billion of bonds on Tuesday, seizing on a low-interest rate environment…

Bristol-Myers Squibb And BMS-986036 In NASH: An Update

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Stocks Gets Boost as Analyst Touts Celgene Acquisition

Barclays analyst Geoff Meacham thinks that the companies’ combined drug pipelines make Bristol-Myers a force to watch in the years…

Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…